Stockhouse.com and BioMark Interview About Early Cancer Detection Podcast - Biomark Diagnostics

Articles and Information

June 21, 2016

Stockhouse.com and BioMark Interview About Early Cancer Detection Podcast

BioMark Diagnostics Inc.

BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.

Interview with BioMark CEO Rashid Ahmed about the importance of early cancer detection and details of how the BioMark technology works. [podcast_episode episode=”2159″ content=”title,excerpt,player”]

Share this post:

Categories

Archives

Sign up for the latest Biomark news

No paperwork, no hassle. We keep things digital, easy and regular.

*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.

BioMark Diagnostics Inc.

CSE: BUX
OTC: BMKDF
FSE: 20B

More Information

Investors

Related articles ...

biomark-press-release

News

Press Release – BioMark Diagnostics Announces Expansion of its Specialty Laboratory Services in Quebec to Accommodate Increased Demand from International Partnerships

Press Release – BioMark Diagnostics Announces Expansion of its Specialty Laboratory Services in Quebec to

August 11, 2025

biomark-press-release

News

Press Release – BioMark Diagnostics Highlights Fiscal Year 2025 Achievements and Sets Bold Strategic Milestones for 2025 – 2026

BioMark Diagnostics Highlights Fiscal Year 2025 Achievements and Sets Bold Strategic Milestones for 2025 –

August 11, 2025

biomark-progress-report

Articles and Information

Form 7 Monthly Progress Report June 2025

Form 7 Monthly Progress Report June 2025 Name of Listed Issuer: Trading Symbol: Number of

July 8, 2025

biomark-press-release

News

Press Release – BioMark Diagnostics Announces Breakthrough Publication Reinforcing Leadership in AI-Powered Metabolomics for Oncology

Novel Graph Neural Network (N-GNN) Model Achieves Superior Accuracy in Early Lung Cancer Detection, Paving

June 3, 2025

biomark-progress-report

Articles and Information

Form 7 Monthly Progress Report May 2025

Form 7 Monthly Progress Report May 2025 Name of Listed Issuer: Trading Symbol: Number of

June 3, 2025

1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2

Pages

Latest Posts

Site Policies

© 2024 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.